Rebecca Pankove

Title: The Innovative Contributions of Rebecca Pankove

Introduction

Rebecca Pankove is a notable inventor based in Atlanta, GA (US). She has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic approaches. With a total of 2 patents, her work focuses on the intersection of nanoparticles and cancer treatment.

Latest Patents

Rebecca Pankove's latest patents include groundbreaking research on nanoparticles conjugated with vasoactive intestinal peptide antagonists. This disclosure relates to compositions that comprise an antagonist of vasoactive intestinal polypeptide signaling coupled to a nanoparticle, along with methods of use related to these compositions. In certain embodiments, the nanoparticle is a poloxamer-stabilized polypropylene sulfide nanoparticle. Another significant patent involves VIP antagonists and their uses in treating cancer. This disclosure outlines methods for treating cancer or viral infections by administering an effective amount of a VIP antagonist in combination with an immune checkpoint inhibitor to a subject in need. In specific embodiments, the immune checkpoint inhibitor is an anti-PD1 or anti-PDL1 antibody.

Career Highlights

Throughout her career, Rebecca has worked with esteemed institutions such as Emory University and Georgia Tech Research Corporation. Her research has contributed to advancements in therapeutic strategies, particularly in oncology.

Collaborations

Rebecca has collaborated with notable professionals in her field, including Edmund K Waller and Susan Thomas. These collaborations have further enhanced her research and innovation efforts.

Conclusion

Rebecca Pankove's innovative work in the field of biomedical research exemplifies the impact of her inventions on cancer treatment. Her contributions continue to pave the way for new therapeutic approaches that may benefit many patients in the future.